Regeneron Pharmaceuticals, Inc. (REGN): Not A Time To Panic Nor Freeze
Regeneron Pharmaceuticals, Inc. (REGN) concluded trading on Thursday at a closing price of $962.49, with 0.45 million shares of worth about $434.78 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 15.61% during that period and on March 28, 2024 the price saw a […]
